Nifty

:

23431.50

Sensex

:

77378.91

-95.00 (-0.40%)
-241.30 (-0.31%)

Login

Menu

Nifty
Sensex

:
:

23431.50
77378.91

-95.00 (-0.40%)
-241.30 (-0.31%)

Dishman Carbogen Amcis Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 540701 | NSE: DCAL

Watchlist

NSE BSE

266.10

10-Jan-2025

Open
High
Low
Previous Close

272.70
277.90
263.10
276.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

820005
2212.85
307.98
133.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,175.92
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,949.29
N/A
0.73

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
5.06
6.91

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-11.91
-4.12

PAT CAGR (%)

10 Years
5 Years
3 Years

65.36
-
35.86

P:E (Median)

8 Years
5 Years
3 Years

9.17
-
-

P:BV (Average)

8 Years
5 Years
3 Years

3.17
0.91
1.24

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.90
10.18
11.68

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS -4.87
P/E Ratio
Revenue 327
EBITDA 16
Net Income -76
ROA -1.5
P/Bk Ratio 0.89
ROE -1.87
FCFF -5.78
FCFF Yield -0.1

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 93.29 59.72 56.21% 103.41 69.55 48.68% 111.26 113.13 -1.65% 86.82 78.40 10.74%
Expenses 79.89 62.64 27.54% 88.51 74.57 18.69% 99.69 106.78 -6.64% 83.65 81.60 2.51%
EBITDA 13.40 -2.92 - 14.90 -5.02 - 11.57 6.35 82.20% 3.17 -3.20 -
EBIDTM 14.36% -4.89% 14.41% -7.22% 10.40% 5.61% 3.65% -4.08%
Other Income 23.93 38.71 -38.18% 11.59 14.44 -19.74% -3.21 14.79 - 13.11 12.36 6.07%
Interest 15.59 17.42 -10.51% 15.73 17.76 -11.43% 15.87 17.03 -6.81% 17.14 14.66 16.92%
Depreciation 16.30 24.58 -33.69% 16.32 24.69 -33.90% 26.12 23.45 11.39% 26.22 2.89 807.27%
PBT 5.44 -9.26 - -5.56 -33.03 - -33.63 -19.34 - -27.08 -10.39 -
Tax -8.81 -3.48 - -2.09 -11.70 - -2.51 -9.11 - -8.90 -3.85 -
PAT 14.25 -5.78 - -3.47 -21.33 - -31.12 -10.23 - -18.18 -6.54 -
PATM 15.27% -9.68% -3.36% -30.67% -27.97% -9.04% -20.94% -8.34%
EPS 0.91 -0.37 - -0.22 -1.36 - -1.98 -0.65 - -1.16 -0.42 -

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 789.04 586.59 34.51% 523.78 723.38 -27.59% 654.71 618.56 5.84% 651.09 639.79 1.77%
Expenses 641.89 525.74 22.09% 494.81 601.52 -17.74% 592.03 567.12 4.39% 609.98 525.92 15.98%
EBITDA 147.15 60.85 141.82% 28.97 121.86 -76.23% 62.68 51.44 21.85% 41.11 113.87 -63.90%
EBIDTM 18.65% 10.37% 5.53% 16.85% 9.57% 8.32% 6.31% 17.80%
Other Income 6.65 8.47 -21.49% 1.43 6.53 -78.10% 7.16 6.75 6.07% 6.05 6.50 -6.92%
Interest 36.63 27.49 33.25% 31.93 28.45 12.23% 30.95 24.43 26.69% 33.08 21.91 50.98%
Depreciation 72.09 75.04 -3.93% 70.59 70.45 0.20% 85.00 75.74 12.23% 80.37 50.33 59.69%
PBT 42.12 -36.26 - -77.56 29.49 - -49.20 -87.60 - -66.29 45.60 -
Tax 9.03 4.64 94.61% 0.01 12.49 -99.92% 20.72 -16.88 - -6.66 -1.36 -
PAT 33.09 -40.90 - -77.57 17.00 - -69.92 -70.72 - -59.63 46.96 -
PATM 4.19% -6.97% -14.81% 2.35% -10.68% -11.43% -9.16% 7.34%
EPS 2.11 -2.61 - -4.95 1.08 - -4.46 -4.51 - -3.80 2.99 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 394.78 327.35 402.55 306.61 200.32 580.74 549.47 474.46 451.49 6.81 0.00 Net Sales Growth 23.06% -18.68% 31.29% 53.06% -65.51% 5.69% 15.81% 5.09% 6529.81% 0 Cost Of Goods Sold 156.52 115.97 171.35 99.41 97.58 200.11 162.58 155.31 142.07 0.00 0.00 Gross Profit 238.26 211.38 231.20 207.20 102.74 380.63 386.89 319.15 309.42 6.81 0.00 GP Margin 60.35% 64.57% 57.43% 67.58% 51.29% 65.54% 70.41% 67.27% 68.53% 100% 0 Total Expenditure 351.74 320.55 394.79 272.82 253.11 407.18 355.68 315.57 303.36 5.13 0.00 Power & Fuel Cost - 28.71 33.07 24.83 12.78 35.27 31.44 28.48 26.36 0.00 0.00 % Of Sales - 8.77% 8.22% 8.10% 6.38% 6.07% 5.72% 6.00% 5.84% 0% 0 Employee Cost - 91.54 86.13 79.04 58.23 88.87 80.27 61.67 66.76 0.00 0.00 % Of Sales - 27.96% 21.40% 25.78% 29.07% 15.30% 14.61% 13.00% 14.79% 0% 0 Manufacturing Exp. - 38.08 43.20 30.48 22.70 37.31 40.40 23.46 27.03 0.00 0.00 % Of Sales - 11.63% 10.73% 9.94% 11.33% 6.42% 7.35% 4.94% 5.99% 0% 0 General & Admin Exp. - 28.56 31.28 30.43 21.08 24.91 31.58 22.42 27.66 5.08 0.00 % Of Sales - 8.72% 7.77% 9.92% 10.52% 4.29% 5.75% 4.73% 6.13% 74.60% 0 Selling & Distn. Exp. - 3.76 9.27 7.68 4.10 7.18 5.38 10.65 8.51 0.00 0.00 % Of Sales - 1.15% 2.30% 2.50% 2.05% 1.24% 0.98% 2.24% 1.88% 0% 0 Miscellaneous Exp. - 13.93 20.49 0.95 36.64 13.53 4.03 13.58 4.97 0.05 0.00 % Of Sales - 4.26% 5.09% 0.31% 18.29% 2.33% 0.73% 2.86% 1.10% 0.73% 0 EBITDA 43.04 6.80 7.76 33.79 -52.79 173.56 193.79 158.89 148.13 1.68 0.00 EBITDA Margin 10.90% 2.08% 1.93% 11.02% -26.35% 29.89% 35.27% 33.49% 32.81% 24.67% 0 Other Income 45.42 63.05 52.16 66.11 66.29 69.57 71.68 73.07 70.80 0.32 0.45 Interest 64.33 68.19 57.92 37.23 34.17 47.02 47.43 35.34 39.17 0.99 0.94 Depreciation 84.96 101.61 96.20 140.07 141.35 140.65 136.31 134.45 135.85 0.00 0.00 PBT -60.83 -99.95 -94.20 -77.40 -162.02 55.46 81.73 62.17 43.91 1.01 -0.50 Tax -22.31 -26.59 -37.33 -52.84 64.12 16.94 25.72 25.10 19.67 0.12 0.00 Tax Rate 36.68% 25.82% 38.80% 63.43% -39.58% 30.54% 31.47% 40.37% 44.80% 11.88% 0.00% PAT -38.52 -76.41 -58.87 -30.47 -226.14 38.52 56.01 37.07 24.24 0.89 -0.50 PAT before Minority Interest -38.52 -76.41 -58.87 -30.47 -226.14 38.52 56.01 37.07 24.24 0.89 -0.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -9.76% -23.34% -14.62% -9.94% -112.89% 6.63% 10.19% 7.81% 5.37% 13.07% 0 PAT Growth 0.00% - - - - -31.23% 51.09% 52.93% 2,623.60% - EPS -2.46 -4.87 -3.75 -1.94 -14.42 2.46 3.57 2.36 1.55 0.06 -0.03

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 2,618.62 2,615.77 2,412.92 2,140.69 1,912.03 2,043.60 2,058.60 1,694.79 1,713.69 Net Sales Growth 1.96% 8.41% 12.72% 11.96% -6.44% -0.73% 21.47% -1.10% Cost Of Goods Sold 556.44 597.19 516.82 447.42 468.15 458.72 403.78 336.93 329.30 Gross Profit 2,062.18 2,018.58 1,896.10 1,693.27 1,443.88 1,584.88 1,654.82 1,357.86 1,384.39 GP Margin 78.75% 77.17% 78.58% 79.10% 75.52% 77.55% 80.39% 80.12% 80.78% Total Expenditure 2,338.71 2,351.85 2,080.72 1,815.04 1,637.82 1,546.04 1,506.70 1,256.77 1,260.34 Power & Fuel Cost - 104.29 87.57 62.58 41.28 60.26 56.79 48.67 49.74 % Of Sales - 3.99% 3.63% 2.92% 2.16% 2.95% 2.76% 2.87% 2.90% Employee Cost - 1,208.16 1,029.86 981.49 872.91 762.27 714.64 625.40 596.02 % Of Sales - 46.19% 42.68% 45.85% 45.65% 37.30% 34.71% 36.90% 34.78% Manufacturing Exp. - 209.66 171.92 144.91 118.31 118.03 114.69 83.69 98.02 % Of Sales - 8.02% 7.12% 6.77% 6.19% 5.78% 5.57% 4.94% 5.72% General & Admin Exp. - 159.33 142.69 104.71 82.76 90.42 157.80 112.15 81.58 % Of Sales - 6.09% 5.91% 4.89% 4.33% 4.42% 7.67% 6.62% 4.76% Selling & Distn. Exp. - 24.80 35.47 29.44 21.94 23.40 20.90 18.56 58.54 % Of Sales - 0.95% 1.47% 1.38% 1.15% 1.15% 1.02% 1.10% 3.42% Miscellaneous Exp. - 48.42 96.39 44.49 32.47 32.94 38.10 31.37 47.14 % Of Sales - 1.85% 3.99% 2.08% 1.70% 1.61% 1.85% 1.85% 2.75% EBITDA 279.91 263.92 332.20 325.65 274.21 497.56 551.90 438.02 453.35 EBITDA Margin 10.69% 10.09% 13.77% 15.21% 14.34% 24.35% 26.81% 25.85% 26.45% Other Income 21.29 50.79 27.77 49.14 38.59 44.46 53.82 53.02 26.13 Interest 132.59 119.97 85.69 56.81 47.61 61.95 56.55 48.83 49.01 Depreciation 308.05 310.86 280.72 307.59 307.94 282.87 240.38 211.42 213.50 PBT -150.93 -116.12 -6.44 10.39 -42.75 197.20 308.79 230.79 216.97 Tax 23.10 31.19 -24.79 -22.26 100.10 38.69 98.46 76.22 70.65 Tax Rate -15.31% -25.51% 45.41% 523.76% -153.93% 19.62% 31.89% 33.03% 32.56% PAT -174.03 -153.45 -29.80 18.01 -165.13 158.51 210.33 154.57 146.32 PAT before Minority Interest -174.03 -153.45 -29.80 18.01 -165.13 158.51 210.33 154.57 146.32 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -6.65% -5.87% -1.24% 0.84% -8.64% 7.76% 10.22% 9.12% 8.54% PAT Growth 0.00% - - - - -24.64% 36.07% 5.64% EPS -11.10 -9.79 -1.90 1.15 -10.53 10.11 13.41 9.86 9.33

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 4,052.58 4,114.31 4,231.78 4,674.62 4,795.85 4,892.37 4,791.58 4,770.74 0.33 -0.56 Share Capital 31.36 31.36 31.36 31.36 31.38 32.28 32.28 0.00 0.05 0.05 Total Reserves 4,021.22 4,082.95 4,200.42 4,643.26 4,764.47 4,860.09 4,759.30 -39.26 0.28 -0.61 Non-Current Liabilities 552.47 572.25 578.46 493.37 494.60 397.81 651.80 364.95 8.98 10.26 Secured Loans 157.37 162.57 134.42 144.41 137.90 202.73 279.37 144.62 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.98 10.26 Long Term Provisions 154.10 154.06 154.80 154.38 185.00 8.03 166.38 6.59 0.00 0.00 Current Liabilities 618.73 641.60 551.19 530.88 620.44 525.93 520.87 401.16 2.80 2.61 Trade Payables 115.88 85.34 53.82 54.42 85.92 93.68 88.15 58.14 0.00 0.00 Other Current Liabilities 182.62 174.55 219.77 186.18 191.52 144.15 173.91 85.45 2.65 2.61 Short Term Borrowings 318.44 379.79 275.70 288.24 340.97 283.88 256.97 256.31 0.00 0.00 Short Term Provisions 1.79 1.92 1.90 2.04 2.03 4.22 1.84 1.26 0.15 0.00 Total Liabilities 5,223.78 5,328.16 5,361.43 5,698.87 5,910.89 5,816.11 5,964.25 5,536.85 12.11 12.31 Net Block 1,415.63 1,382.30 1,355.98 1,509.65 1,632.53 1,715.32 1,852.82 1,927.08 0.00 0.00 Gross Block 2,572.51 2,456.61 2,338.73 2,364.26 2,344.45 2,286.96 2,293.17 2,233.75 0.00 0.00 Accumulated Depreciation 1,156.88 1,074.31 982.75 854.61 711.92 571.64 440.35 306.67 0.00 0.00 Non Current Assets 4,636.56 4,678.55 4,595.64 4,975.81 5,146.20 5,079.83 5,210.82 4,767.34 0.00 0.00 Capital Work in Progress 74.05 142.89 117.77 121.20 88.85 69.78 47.89 40.55 0.00 0.00 Non Current Investment 2,834.26 2,837.36 2,811.09 2,814.87 2,843.10 2,886.97 2,842.75 2,593.82 0.00 0.00 Long Term Loans & Adv. 311.95 315.19 310.14 529.74 576.27 406.44 462.42 191.96 0.00 0.00 Other Non Current Assets 0.67 0.81 0.66 0.35 5.45 1.32 4.94 13.93 0.00 0.00 Current Assets 587.22 649.61 765.79 723.06 764.69 736.28 753.43 769.51 12.11 12.31 Current Investments 13.90 75.49 221.19 66.84 57.01 19.72 94.35 167.37 0.00 0.00 Inventories 169.62 182.66 196.90 184.40 213.64 222.61 169.09 151.80 0.00 0.00 Sundry Debtors 183.70 146.80 65.66 118.89 144.90 130.15 140.02 71.18 0.00 0.00 Cash & Bank 9.90 68.43 86.47 80.32 65.13 47.35 21.29 40.31 0.60 0.01 Other Current Assets 210.10 29.76 52.44 91.71 284.01 316.45 328.68 338.85 11.51 12.29 Short Term Loans & Adv. 180.80 146.47 143.13 180.90 230.24 224.13 261.20 285.81 10.81 12.29 Net Current Assets -31.51 8.01 214.60 192.18 144.25 210.35 232.56 368.35 9.31 9.69 Total Assets 5,223.78 5,328.16 5,361.43 5,698.87 5,910.89 5,816.11 5,964.25 5,536.85 12.11 12.31

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 5,627.50 5,809.67 5,548.94 5,698.82 5,715.06 5,379.09 5,107.33 4,813.98 Share Capital 31.36 31.36 31.36 31.36 31.38 32.28 32.28 0.00 Total Reserves 5,596.14 5,778.31 5,517.58 5,667.46 5,683.68 5,346.81 5,075.05 3.98 Non-Current Liabilities 1,388.40 1,831.43 1,665.47 1,366.74 909.40 743.13 883.95 766.66 Secured Loans 245.61 1,046.65 761.96 503.94 222.41 310.55 386.16 241.45 Unsecured Loans 0.00 0.00 0.00 0.00 18.89 51.87 138.81 218.67 Long Term Provisions 379.04 233.16 277.09 310.99 294.08 248.31 234.34 221.40 Current Liabilities 2,554.72 1,798.39 1,419.79 1,290.30 1,568.95 1,198.31 1,177.72 993.66 Trade Payables 244.12 219.73 193.37 169.23 283.52 194.57 185.92 85.64 Other Current Liabilities 639.53 841.64 702.41 558.68 578.83 430.36 515.88 457.19 Short Term Borrowings 1,620.23 680.76 492.64 542.47 688.23 520.09 393.31 384.95 Short Term Provisions 50.84 56.26 31.37 19.92 18.37 53.29 82.61 65.88 Total Liabilities 9,570.62 9,439.49 8,634.20 8,355.86 8,193.41 7,320.53 7,169.00 6,574.30 Net Block 6,720.08 6,183.17 5,768.14 5,693.34 5,672.85 5,092.37 5,060.70 4,847.25 Gross Block 10,308.49 9,457.72 8,633.43 8,155.29 7,890.70 6,896.88 6,621.19 6,187.07 Accumulated Depreciation 3,588.41 3,274.55 2,865.29 2,461.95 2,217.85 1,804.51 1,560.49 1,339.82 Non Current Assets 7,642.43 7,521.13 6,795.48 6,651.72 6,414.44 5,766.95 5,622.85 5,241.25 Capital Work in Progress 645.74 1,043.25 779.51 485.78 234.17 175.25 150.71 132.88 Non Current Investment 78.85 72.10 31.83 55.78 89.09 152.61 106.60 44.25 Long Term Loans & Adv. 192.78 217.24 210.78 411.53 412.88 345.40 299.33 200.63 Other Non Current Assets 0.66 0.81 0.66 0.35 5.45 1.32 5.51 16.24 Current Assets 1,928.19 1,918.36 1,838.72 1,704.14 1,778.97 1,553.58 1,546.15 1,333.05 Current Investments 23.29 176.97 292.53 116.44 106.61 19.72 94.35 0.00 Inventories 882.89 803.80 645.12 515.65 580.87 548.62 484.56 426.58 Sundry Debtors 461.11 589.91 473.42 420.71 577.43 445.30 444.40 285.55 Cash & Bank 413.35 189.17 172.09 307.74 160.98 95.67 69.06 87.39 Other Current Assets 147.55 37.54 66.08 146.03 353.08 444.27 453.78 533.53 Short Term Loans & Adv. 79.04 120.97 189.48 197.57 277.10 309.17 373.27 361.20 Net Current Assets -626.53 119.97 418.93 413.84 210.02 355.27 368.43 339.39 Total Assets 9,570.62 9,439.49 8,634.20 8,355.86 8,193.41 7,320.53 7,169.00 6,574.30

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 24.17 -52.90 227.35 -1.51 196.68 119.73 20.05 270.38 2.57 -1.31 PBT -103.00 -96.20 -84.39 -168.69 55.46 81.73 62.17 43.91 1.01 -0.50 Adjustment 116.86 100.96 117.32 128.11 135.32 122.26 106.13 84.59 0.71 0.50 Changes in Working Capital 11.53 -54.11 200.55 46.25 24.14 -64.57 -122.65 179.09 0.97 -0.36 Cash after chg. in Working capital 25.39 -49.35 233.48 5.67 214.92 139.42 45.65 307.59 2.69 -0.36 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.94 Tax Paid -1.22 -3.55 -6.13 -7.18 -18.24 -19.69 -25.60 -37.21 -0.12 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 96.57 40.71 -172.67 62.07 -74.30 -24.17 -174.61 -19.15 0.28 0.45 Net Fixed Assets -47.06 -143.00 28.96 -52.16 -76.56 -15.68 -66.76 -2,274.30 0.00 0.00 Net Investments 64.69 119.43 -150.57 18.40 6.58 30.41 -175.91 -2,761.19 0.00 0.00 Others 78.94 64.28 -51.06 95.83 -4.32 -38.90 68.06 5,016.34 0.28 0.45 Cash from Financing Activity -130.76 1.38 -46.16 -70.53 -124.07 -85.32 142.45 -225.38 -2.28 0.85 Net Cash Inflow / Outflow -10.02 -10.81 8.52 -9.97 -1.69 10.24 -12.11 25.85 0.57 -0.01 Opening Cash & Equivalents 14.07 24.88 16.36 26.33 28.01 17.77 29.86 0.58 0.01 0.03 Closing Cash & Equivalent 4.05 14.07 24.88 16.36 26.32 28.01 17.75 29.86 0.58 0.01

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 383.97 265.95 354.85 512.66 585.14 282.03 226.44 302.65 PBT -122.26 -54.59 -4.25 -65.03 197.20 308.79 230.79 216.08 Adjustment 381.37 392.46 325.36 312.54 330.11 277.24 235.49 231.80 Changes in Working Capital 143.83 -37.73 90.08 316.35 132.23 -174.47 -206.26 -29.43 Cash after chg. in Working capital 402.94 300.14 411.19 563.86 659.54 411.56 260.02 418.45 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -18.97 -34.19 -56.34 -51.20 -74.40 -129.53 -33.58 -115.80 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -229.52 -494.08 -618.53 -380.02 -441.74 -169.02 -297.16 -142.41 Net Fixed Assets -47.06 -143.00 28.96 -52.16 -76.56 -15.68 -66.76 Net Investments 64.69 119.43 -150.57 18.40 6.58 30.41 -175.91 Others -247.15 -470.51 -496.92 -346.26 -371.76 -183.75 -54.49 Cash from Financing Activity -22.15 249.68 130.37 -11.04 -97.78 -102.20 77.63 -137.08 Net Cash Inflow / Outflow 132.30 21.55 -133.31 121.60 45.62 10.81 6.91 23.16 Opening Cash & Equivalents 131.79 110.24 243.55 121.94 76.32 65.52 58.61 0.00 Closing Cash & Equivalent 264.09 131.79 110.24 243.54 121.94 76.33 65.52 58.61

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 258.46 262.39 269.88 298.13 305.66 303.12 296.88 0.00 13.20 -112.84 ROA -1.45% -1.10% -0.55% -3.90% 0.66% 0.96% 0.64% 0.87% 7.29% -4.06% ROE -1.87% -1.41% -0.68% -4.78% 0.80% 1.16% 1.56% 0.00% 0.00% 0.00% ROCE -0.75% -0.81% -0.93% -2.42% 1.89% 2.37% 1.83% 3.18% 21.05% 4.09% Fixed Asset Turnover 0.13 0.17 0.13 0.09 0.25 0.24 0.21 0.20 0.00 0.00 Receivable days 184.26 96.32 109.85 240.32 86.44 89.73 81.24 57.54 0.00 0.00 Inventory Days 196.40 172.08 226.96 362.63 137.09 130.10 123.43 122.72 0.00 0.00 Payable days 316.66 148.22 198.71 262.47 62.88 68.69 64.15 51.65 0.00 0.00 Cash Conversion Cycle 64.00 120.18 138.09 340.48 160.65 151.14 140.51 128.61 0.00 0.00 Total Debt/Equity 0.13 0.14 0.12 0.11 0.12 0.12 0.13 -11.33 27.21 -18.18 Interest Cover -0.51 -0.66 -1.24 -3.74 2.18 2.72 2.76 2.12 2.02 0.47

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 358.90 370.51 353.89 363.45 364.25 333.28 316.44 0.00 ROA -1.61% -0.33% 0.21% -2.00% 2.04% 2.90% 2.25% 2.23% ROE -2.68% -0.52% 0.32% -2.89% 2.86% 4.01% 6.05% 3676.38% ROCE -0.03% 0.43% 0.76% -0.26% 3.93% 5.79% 4.67% 4.61% Fixed Asset Turnover 0.26 0.27 0.26 0.24 0.28 0.30 0.26 0.28 Receivable days 73.33 80.42 76.23 95.27 91.33 78.87 78.60 60.82 Inventory Days 117.68 109.59 98.96 104.66 100.87 91.59 98.11 90.86 Payable days 141.75 145.87 147.90 176.50 49.83 43.67 37.47 22.81 Cash Conversion Cycle 49.26 44.14 27.28 23.44 142.37 126.80 139.24 128.86 Total Debt/Equity 0.35 0.31 0.26 0.20 0.18 0.19 0.21 238.62 Interest Cover -0.02 0.36 0.93 -0.37 4.18 6.46 5.73 5.43

Top Investors:

mukul mahavir agrawal

hbm healthcare investments (cayman) ltd

massachusetts institute of technology

investor education and protection fund (iepf)

Annual Reports:

News Update:

Dishman Carbogen Amcis’ arm completes Swissmedic inspection of Vionnaz facility
10th Jan 2025, 14:58 PM

It reinforces CARBOGEN AMCIS’s strong history of compliance with Swissmedic requirements
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback